Author:
Gobbi Alberto,Herman Katarzyna,Szwedowski Dawid
Abstract
Osteoarthritis is a major cause of functional limitation and a raising burden in aging population. Lately more research is directed into finding biological enhancement of healing processes in joint dysfunctions. Biological cell-based therapies for cartilage restoration treatment were created to address the need for the long-term viability of repaired tissues. Additionally, the use of biologic therapies is also considered in common disorders affecting ligaments and cartilage. However, if inevitable arthritic changes commence biological therapies offer options to delay the need for arthroplasty. This chapter provides insights into these regenerative, joint preservation techniques for cartilage treatment, osteoarthritis, and other joint disorders.
Reference80 articles.
1. Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: A lancet commission. The Lancet. 2020;396(10264):1711-1712
2. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) results. 2020. [Internet]. [cited 2021 Aug 10]. Available from: http://ghdx.healthdata.org/gbd-results-tool. [Accessed: August 8, 2020]
3. Gobbi A, Lane JG, Espregueira-Mendes J, Karahan M. Bio-Orthopaedics: A New Approach. Bio-orthopaedics: A New Approach; 2017. pp. 1-696
4. Herman K, Gobbi A. Evidence-based approach to Orthobiologics for osteoarthritis and other joint disorders. Physical Medicine and Rehabilitation Clinics of North America. 2023;34(1):71-81
5. Salamanna F, Veronesi F, Maglio M, Della Bella E, Sartori M, Fini M. New and emerging strategies in platelet-rich plasma application in musculoskeletal regenerative procedures: General overview on still open questions and outlook. BioMed Research International. 2015;2015:846045. DOI: 10.1155/2015/846045. E